PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy

T P Vassilakopoulos¹, G A Pangalis², S Chatziioannou³, S Papageorgiou⁴, M K Angelopoulou¹, Z Galani⁵, G Kourti⁶, V Prassopoulos⁷, T Leonidopoulou⁸, E Terpos⁹, M N Dimopoulou¹, S Sachanas², C Kalpadakis¹⁰, P Konstantinidou¹¹, D Boutsis¹², E Stefanoudaki¹³, L Kyriazopoulou¹⁴, M P Siakantaris¹⁵, M-C Kyrtsonis¹⁶, E Variami¹⁵, I Kotsianidis¹⁷, A Symeonidis¹⁸, E Michali¹⁹, E Katodritou¹¹, G Kokkini⁸, C Tsatalas¹⁷, H Papadaki¹⁰, M-A Dimopoulos⁹, V Sotiropoulos²⁰, V Pappa⁴, T Karmiris⁶, J Meletis¹, J Apostolidis⁶, I Datseris²¹, P Panayiotidis¹⁶, K Konstantopoulos¹, P Roussou⁵, P Rondogianni²¹

Affiliations

¹ Department of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
² Department of Haematology, Athens Medical Center, Psychikon Branch, Athens, Greece.
³ Department of Nuclear Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece.
⁴ Second Propedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Attikon Hospital, Athens, Greece.
⁵ Third Department of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece.
⁶ Department of Haematology and Lymphoma, Evangelismos General Hospital, Athens, Greece.
⁷ Department of Nuclear Medicine, HYGEIA Hospital, Athens, Greece.
⁸ Department of Haematology, Sismanoglion General Hospital, Athens, Greece.
⁹ Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
¹⁰ Department of Haematology, University of Crete, Iraklion, Greece.
¹¹ Department of Haematology, Theagenion Anticancer General Hospital, Thessaloniki, Greece.
¹² Department of Haematology, Athens Navy Hospital, Athens, Greece.
¹³ Department of Haematology, Amalia Fleming Hospital, Athens, Greece.
¹⁴ Department of Haematology, University of Ioannina, Ioannina, Greece.
¹⁵ First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
¹⁶ First Propedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
¹⁷ Department of Haematology, Democritus University of Thrace, Alexandroupolis, Greece.
¹⁸ Hematology Division, Department of Internal Medicine, University of Patras, Patras, Greece.
¹⁹ Department of Clinical Haematology, "G.Gennimatas" Athens General Hospital, Athens, Greece.
²⁰ Department of Nuclear Medicine and PET/CT, Athens Medical Center, Athens, Greece.
²¹ Department of Nuclear Medicine and PET/CT, Evangelismos General Hospital, Athens, Greece.

PMID: 25971363
DOI: 10.1038/leu.2015.120

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy

T P Vassilakopoulos et al. Leukemia. 2016 Jan.

. 2016 Jan;30(1):238-42.

doi: 10.1038/leu.2015.120. Epub 2015 May 14.

Authors

Affiliations

¹ Department of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
² Department of Haematology, Athens Medical Center, Psychikon Branch, Athens, Greece.
³ Department of Nuclear Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece.
⁴ Second Propedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Attikon Hospital, Athens, Greece.
⁵ Third Department of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece.
⁶ Department of Haematology and Lymphoma, Evangelismos General Hospital, Athens, Greece.
⁷ Department of Nuclear Medicine, HYGEIA Hospital, Athens, Greece.
⁸ Department of Haematology, Sismanoglion General Hospital, Athens, Greece.
⁹ Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
¹⁰ Department of Haematology, University of Crete, Iraklion, Greece.
¹¹ Department of Haematology, Theagenion Anticancer General Hospital, Thessaloniki, Greece.
¹² Department of Haematology, Athens Navy Hospital, Athens, Greece.
¹³ Department of Haematology, Amalia Fleming Hospital, Athens, Greece.
¹⁴ Department of Haematology, University of Ioannina, Ioannina, Greece.
¹⁵ First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
¹⁶ First Propedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
¹⁷ Department of Haematology, Democritus University of Thrace, Alexandroupolis, Greece.
¹⁸ Hematology Division, Department of Internal Medicine, University of Patras, Patras, Greece.
¹⁹ Department of Clinical Haematology, "G.Gennimatas" Athens General Hospital, Athens, Greece.
²⁰ Department of Nuclear Medicine and PET/CT, Athens Medical Center, Athens, Greece.
²¹ Department of Nuclear Medicine and PET/CT, Evangelismos General Hospital, Athens, Greece.

PMID: 25971363
DOI: 10.1038/leu.2015.120

No abstract available

PubMed Disclaimer

Comment in

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP.
Lontos K. Lontos K. Leukemia. 2016 Aug;30(8):1799-800. doi: 10.1038/leu.2016.103. Epub 2016 May 17. Leukemia. 2016. PMID: 27183879 No abstract available.

References

1. J Clin Oncol. 1999 Apr;17(4):1244 - PubMed
1. Leuk Lymphoma. 2015 Jan;56(1):49-56 - PubMed
1. Leuk Lymphoma. 2014 Mar;55(3):538-43 - PubMed
1. Ann Hematol. 2014 Aug;93(8):1297-304 - PubMed
1. Am J Hematol. 2011 Dec;86(12):E61-4 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy

Affiliations

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy

Authors

Affiliations

Comment in

References

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources

Full Text Sources

Research Materials